|
|||||
|
|
| 肿瘤分子靶向治疗药物的应用进展 | |
| 引用本文： | 詹琼. 肿瘤分子靶向治疗药物的应用进展[J]. 上海医药, 2011, 32(12): 577-581 |
| 作者姓名： | 詹琼 |
| 作者单位： | 复旦大学附属华山医院肿瘤科,上海,200040 |
| 摘 要： | 分子靶向治疗作为肿瘤治疗的新手段,正以其低毒、副反应和高治疗效果成为肿瘤治疗研究的热点.按作用靶点以及药物的性质,分子靶向药物可分为数类,主要包括以EGFR为靶点的药物、作用于HER2/erbB2的单克隆抗体、靶向VEGF/VEGFR的药物、以白细胞CD为靶点的单克隆抗体以及作用于多个靶点的药物.本文综述肿瘤分子靶向治... |
| 关 键 词： | 肿瘤 分子靶向治疗 药物 |
Progress in the application of molecular targeted drugs for cancer therapy |
|
| ZHAN Qiong. Progress in the application of molecular targeted drugs for cancer therapy[J]. Shanghai Medical & Pharmaceutical Journal, 2011, 32(12): 577-581 | |
| Authors: | ZHAN Qiong |
| Affiliation: | ZHAN Qiong(Department of Oncology,Huashan Hospital,Fudan University,Shanghai,200040) |
| Abstract: | Molecular targeted therapy is a newly developed approach for cancer therapy.With the advantages of lower toxicity,tolerable side effects and higher performance,molecular targeted therapeutic drugs(MTTD)have become a critical focus in cancer research.According to the targets and the nature of these drugs,MTTD were divided into several classes,including the drugs targeting EGFR,the monoclonal antibodies to HER2/erbB2,the drugs targeting VEGF/VEGFR,the monoclonal antibodies to CD antigen in white cells,and mul... |
| Keywords: | cancer molecular targeted therapy drugs |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |